The biopharmaceutical arm of Samsung Group, Samsung BioLogics,.... has filed an administrative lawsuit against South Korea's financial regulator over its recent ruling on the firm's accounting violations. <br />Samsung BioLogics also said Wednesday.... that it asked the Seoul Administrative Court to nullify the Financial Services Commission's disciplinary actions.<br />Those actions include.... a fine of around seven million U.S. dollars.... and recommending its CEO be fired. <br />The FSC's Securities and Futures Commission ruled this month.... that Samsung BioLogics intentionally changed the accounting method to inflate the value of its affiliate called Samsung Bioepis in 2015.<br />The company says.... it will prove the legitimacy of its accounting management through the lawsuit. <br />
